10x Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	638.78	642.82	610.79	618.73	516.41	490.49
Revenue Growth (YoY)	2.26%	5.24%	-1.28%	19.81%	5.28%	64.13%
Cost of Revenue	194.17	198.94	196.3	209.41	120.39	74.09
Gross Profit	444.61	443.88	414.48	409.31	396.02	416.4
Selling, General & Admin	292.78	316.13	344.34	343.33	298.3	257.56
Research & Development	231.23	238.63	264.7	270.33	265.67	211.75
Other Operating Expenses	-40.7	49.9	-	60.98	-	-0.66
Total Operating Expenses	483.32	604.67	609.04	674.64	563.97	468.65
Operating Income	-38.7	-60.99	-194.56	-265.33	-167.94	-52.25
Interest Income	21.38	20.05	18.93	16.89	6.65	0.21
Interest Expense	-	-	-0	-0.03	-0.48	-0.87
Other Non-Operating Income (Expense)	-1.92	1.03	-2.07	-0.29	-0.2	-0.8
Total Non-Operating Income (Expense)	19.46	21.08	16.86	16.57	5.97	-1.46
Pretax Income	-19.25	-39.91	-177.7	-248.76	-161.97	-53.72
Provision for Income Taxes	3.41	3.64	4.93	6.34	4.03	4.51
Net Income	-22.66	-43.54	-182.63	-255.1	-166	-58.22
Net Income to Common	-22.66	-43.54	-182.63	-255.1	-166	-58.22
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	126	125	120	117	114	110
Shares Outstanding (Diluted)	126	125	120	117	114	110
Shares Change (YoY)	4.20%	3.57%	2.80%	2.90%	3.18%	9.09%
EPS (Basic)	-0.17	-0.35	-1.52	-2.18	-1.46	-0.53
EPS (Diluted)	-0.17	-0.35	-1.52	-2.18	-1.46	-0.53
EPS Growth	-	-	-	-	-	-
Free Cash Flow	122.18	130.12	-5.73	-63.8	-165.27	-122.65
Free Cash Flow Growth	169.33%	-	-	-	-	-
Free Cash Flow Per Share	0.97	1.04	-0.05	-0.54	-1.45	-1.11
Gross Margin	69.60%	69.05%	67.86%	66.15%	76.69%	84.89%
Operating Margin	-6.06%	-9.49%	-31.85%	-42.88%	-32.52%	-10.65%
Profit Margin	-3.55%	-6.77%	-29.90%	-41.23%	-32.15%	-11.87%
FCF Margin	19.13%	20.24%	-0.94%	-10.31%	-32.00%	-25.01%
EBITDA	7.21	-17.17	-150.85	-221.71	-134.94	-24
EBITDA Margin	1.13%	-2.67%	-24.70%	-35.83%	-26.13%	-4.89%
EBIT	-38.7	-60.99	-194.56	-265.33	-167.94	-52.25
EBIT Margin	-6.06%	-9.49%	-31.85%	-42.88%	-32.52%	-10.65%
Effective Tax Rate	-17.71%	-9.11%	-2.77%	-2.55%	-2.49%	-8.39%

SEC Filings: 10-K · 10-Q